ロード中...
Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
Head and neck squamous cell cancer (HNSCC) is the sixth most common malignancy worldwide, and despite advances in cytotoxic, surgical and radiation techniques, outcomes are still poor in those with both locally advanced and metastatic diseases. The need for development of better therapeutics along w...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587117/ https://ncbi.nlm.nih.gov/pubmed/28919706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S119537 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|